Heidelberg Pharma AG (LON:0QW5)

Heidelberg Pharma AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is December - November.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 3, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Market Capitalization	192	93	111	230	151	145
Market Cap Growth	-12.83%	-16.22%	-51.85%	52.81%	4.13%	172.95%
Enterprise Value	174	63	72	235	139	137
Last Close Price	4.21	1.97	2.41	4.43	5.70	3.42
PS Ratio	33.81	16.33	13.05	14.39	87.04	18.64
PB Ratio	9.24	3.62	2.61	4.00	26.43	12.54
P/TBV Ratio	14.34	5.08	3.18	4.62	-	40.90
EV/Sales Ratio	29.45	11.02	8.49	14.68	80.41	17.60
Debt / Equity Ratio	0.01	0.01	0.12	0.24	1.59	0.02
Asset Turnover	0.12	0.11	0.12	0.30	0.10	0.41
Inventory Turnover	0.15	0.16	0.43	1.76	9.66	23.96
Quick Ratio	4.78	4.42	2.31	2.96	0.51	0.98
Current Ratio	7.15	5.95	2.86	3.15	0.60	1.14
Return on Equity (ROE)	-59.35%	-48.33%	-35.09%	-53.73%	-267.02%	-125.93%
Return on Assets (ROA)	-26.48%	-20.82%	-20.14%	-18.70%	-78.14%	-56.00%
Return on Capital (ROIC)	-40.11%	-31.65%	-24.99%	-22.88%	-106.22%	-81.22%
Earnings Yield	-8.99%	-17.33%	-15.82%	-7.39%	-14.77%	-11.37%
FCF Yield	-12.06%	-26.86%	-26.91%	-3.55%	-15.74%	-11.92%
Buyback Yield / Dilution	-1.47%	-0.02%	-25.14%	-14.56%	-8.72%	-5.98%

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.